Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
Healthy Volunteers
NCT05460468

Neuromodulation of Memory in Aging

Led by Duke University · Updated on 2025-10-14

150

Participants Needed

1

Research Sites

169 weeks

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Institute on Aging (NIA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investigators will study network activation and neural oscillatory mechanisms underlying the network that regulates working memory and then target this network using closed-loop TMS to the Prefrontal Cortex. Investigators will measure the impact of TMS on working memory performance and task-based neural activity. The project will use brain stimulation and network modeling techniques to enhance working memory in healthy older adults and MCI and will demonstrate the value of closed-loop, network-guided TMS for future clinical applications.

CONDITIONS

Official Title

Neuromodulation of Memory in Aging

Who Can Participate

Age: 18Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • English speaking
  • Willing to provide consent
Not Eligible

You will not qualify if you...

  • History of any Axis I DSM-V disorder, excluding major depressive disorder or generalized anxiety disorders
  • Current history of substance abuse or dependence (excluding nicotine)
  • Intracranial implants such as aneurysm clips, shunts, stimulators, cochlear implants, or electrodes
  • Cardiac pacemakers or vagus nerve stimulation device
  • Increased risk of seizure including prior epilepsy diagnosis, seizure disorder, increased intracranial pressure, or significant head trauma with loss of consciousness for 5 minutes or more
  • Neurological disorders including space occupying brain lesion, history of seizures, cerebrovascular accident, fainting, cerebral aneurysm, dementia, Huntington chorea, multiple sclerosis
  • Current use of medications known to lower seizure threshold or affect working memory

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Duke University Hospital

Durham, North Carolina, United States, 27710

Actively Recruiting

Loading map...

Research Team

S

Simon W Davis, PhD

CONTACT

E

Emily Finch, BA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here